Page results
-
This step-by-step guide explains how you can give yourself an injection of bortezomib at home.
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
Postnatal care should be a continuation of the care the woman has received through her pregnancy, labour and birth and take into account the woman’s individual needs and preferences.
-
To mark International Brain Tumour Awareness Week, UCLH and The National Brain Appeal are announcing a new clinical trial for patients with recurrent glioblastoma brain cancer.
-
This page explains what FACETS is and how it can help you.
-
A high quality diagnostic service for surgical neuropathology, neuromuscular diagnostics, epilepsy, molecular neuropathology of brain tumours, and neurodegenerative diseases.
-
Three patients in the UK have received an innovative treatment for the most serious form of lupus – an autoimmune condition which can cause damage to the heart, lungs, joints, brain or kidneys.
-
The UCLH Department of Rheumatology is a UK centre of excellence for clinical care, training and research.
-
Our thoracic/respiratory medicine service offers a comprehensive inpatient and outpatient medical service for adults with conditions affecting the lungs.
-
Information about the integrated women's service at the Royal London Hospital for Integrated Medicine
File results
-
FOI/2023/0007 - Outpatient activity for 2022
-
FOI/2023/0009 - Procedure volumes/ average costs for portable and stable oxygen concentrator devices
-
FOI/2023/0010 - Bardet-biedle Syndrome patient treatment and diagnosis
-
FOI/2023/0013 - Average waiting times for colonoscopy investigations
-
FOI/2023/0014 - Surgery protocols/ standard operating procedures for a feticide
-
FOI/2023/0018 - A&E attendances/ admissions by patients of no fixed abode
-
FOI/2023/0019 - Public access to water refill stations on your premises
-
FOI/2023/0022 - Guidelines staff follow for patients with disabilities and autism
-
FOI/2023/0226 - Treatment with Nivolumab
-
FOI/2023/0225 - Usage of Dabrafenib + Trametinib in cancer treatment